KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Ionis Pharmaceuticals (IONS) Long-Term Debt Issuances (2017 - 2024)

Ionis Pharmaceuticals has reported Long-Term Debt Issuances over the past 5 years, most recently at $44.5 million for Q4 2024.

  • Quarterly results put Long-Term Debt Issuances at $44.5 million for Q4 2024, changed N/A from a year ago — trailing twelve months through Dec 2024 was $44.5 million (down 89.41% YoY), and the annual figure for FY2023 was $575.0 million, changed.
  • Long-Term Debt Issuances for Q4 2024 was $44.5 million at Ionis Pharmaceuticals, down from $420.4 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for IONS hit a ceiling of $420.4 million in Q2 2023 and a floor of -$313.5 million in Q4 2021.
  • Median Long-Term Debt Issuances over the past 3 years was $44.5 million (2024), compared with a mean of $50.5 million.